Australia's Ansell rises to record high, Citi keeps 'neutral' rating

Ansell

07/10/2026 01:50

Updates
** Shares of Australian medical glove maker Ansell ANN.AX rise as much as 1.8% to a record high of A$45.9
** Analysts at Citi maintain "neutral" rating with price target set at A$39.5
** Brokerage says Ansell's competitor Top Glove TPGC.KL reports global demand for gloves outpacing supply growth in its fourth-quarter results
** Both Ansell and Top Glove have been able to pass on rising raw material costs to consumers, keeping margins consistent, Citi says
** Brokerage flags currency movements, especially EURUSD EUR= and volatile prices of materials such as latex as risks for ANN
** Citi estimates 11% core EPS growth in FY27 over FY26, visible alpha consensus at nearly 12% growth
** One of 10 analysts rate the stock "buy" or higher, 9 "hold"; median PT is A$39.1, according to data compiled by LSEG 
** Stock up 29.2% YTD, including the session's moves

 (Reporting by Rudrannsh Mehra in Bengaluru)
 ((Rudrannsh.Mehra@thomsonreuters.com))